VEGFA and Hepatic fibrosis: Inhibition of angiogenesis with multitargeted receptor tyrosine kinase inhibitors [16] and blocking the interactions of VEGF with its receptors have been shown to regress or reverse liver fibrosis in experimental animals [6, 17].